Exelixis Inc (EXEL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access EXEL Annual Cash Flow →
Looking at cash flow data from Exelixis Inc through Apr 04 2025 provides insight into Apr 03 2026's financial flexibility across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Apr 03 2026)
3 Months
(Jan 02 2026) (Oct 03 2025) (Jul 04 2025) (Apr 04 2025)
Operating Activities
Income210.47
Depreciation & amortization6.95
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring Costs and Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-3.39
Research and Development in Process0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation29.05
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease In Operating Lease Right of Use Asset-
Increase Decrease Accrued Clinical Liabilities-
Increase Decrease In Rebates And Fees Payable-
Increase Decreasein Accrued Collaboration Liability-
Increase Decrease In Contract With Customer Liability-
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash-
Noncash Lease Expense5.99
Research And Development Asset Acquired Other Than Through Business Combination Written Off2.03
Income taxes0.00
Gain (Loss) on Sale of Other Investments0.00
Increase (Decrease) in Accounts Receivable-42.03
Increase (Decrease) in Accounts Payable-17.90
Increase (Decrease) in Accrued Liabilities4.04
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets58.65
Other Working Capital0.00
Other Noncash Income (Expense)-2.02
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities251.85
Investing Activities
Capital Expenditures-1.51
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities225.13
Payments to Acquire Marketable Securities-274.16
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-0.53
Proceeds from Sale of Equity Method Investments0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-51.07
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-422.88
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-516.72
Proceeds From Exercise Of Stock Options And Warrants-
Repayments Net From Deconsolidation Of Company-
Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases-
Payments for Conversion of Convertible Debt-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents482.49
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-457.11
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow250.34
Total Cash Flow-256.34
4 historic quarters locked

Sign in to unlock the full Exelixis Inc cash flow history.

About Exelixis Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000939767-26-000098

Figures are derived from filed reports and may be restated. Historical data is subject to revision.